Stephanie Jeffares
St John of God Subiaco Hospital
4 Papers
4 Citations
Stephanie Jeffares is an academic researcher from St John of God Subiaco Hospital. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 1, co-authored 4 publications. Previous affiliations of Stephanie Jeffares include St John of God Health Care.
Chat about Author
Papers
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy.
Paul A. Cohen,Yee Leung,Yee Leung,Lyndal Anderson,Rachael van der Griend,Paola Chivers,Paola Chivers,Sanela Bilic,Sophie Bittinger,Alison Brand,Alison Brand,Max Bulsara,Jim Codde,Lois Eva,Lois Eva,Louise Farrell,Dianne Harker,Unine Herbst,Stephanie Jeffares,Diane Loh,Diane Loh,Orla McNally,Orla McNally,Ganendra Raj Mohan,Ganendra Raj Mohan,Tarryn Nicholson,Aime Powell,Stuart Salfinger,Bryony Simcock,Colin J.R. Stewart,Colin J.R. Stewart,Julie Silvers,Martin R. Stockler,Peter Sykes,Pennie Stoyles,Adeline Tan,Ai Ling Tan,C. David Wrede,C. David Wrede +38 more
TL;DR: LEEP was not associated with a greater likelihood of positive margins, specimen fragmentation or smaller excision when performed according to a standardized protocol and a definitive phase 3 trial to compare margin status and rates of treatment failure after LEEP and CKC is warranted.
8
The impact of bilateral salpingo-oophorectomy on sexuality and quality of life in women with breast cancer.
Paige E. Tucker,Paige E. Tucker,Paul A. Cohen,Paul A. Cohen,Paul A. Cohen,Max Bulsara,Stephanie Jeffares,Christobel Saunders,Christobel Saunders +8 more
TL;DR: In this study, women with prior treatment for breast cancer had high levels of FSD and HSDD, irrespective of whether they had undergone BSO, and both groups reported similar sexual function scores and QoL.
5
Mindfulness-based cognitive therapy for Fear of Recurrence in Ovarian Cancer Survivors (FROCS): a single-arm, open-label, pilot study
TL;DR: In this article, the feasibility of mindfulness-based cognitive therapy (MBCT) to treat fear of cancer recurrence (FCR) in ovarian cancer survivors was evaluated in a single-arm, open-label, pilot study.
4
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer
Paul A. Cohen,Penelope M. Webb,Madeleine King,Andreas Obermair,Val Gebski,Phyllis Butow,Rachael L. Morton,Wanda Lawson,Patsy Yates,Rachel Campbell,Tarek Meniawy,Michelle McMullen,Andrew Dean,Jeffrey C. Goh,Orla McNally,Linda Mileshkin,Philip Beale,Rhonda Beach,Jane Hill,Cyril Dixon,Sue Hegarty,Jim Codde,Angela Ives,Yeh Chen Lee,Alison Brand,Anne Mellon,Sanela Bilic,Isobel Black,Stephanie Jeffares,Michael Friedlander +29 more
TL;DR: In this article, nurse-led follow-up via telehealth, including serum CA125 monitoring and completion of a patient reported outcome instrument, the Measure of Ovarian Symptoms and Treatment concerns-Surveillance (MOST-S26), was shown to improve emotional wellbeing in women with ovarian cancer.